With regard to the National Advisory Committee on Immunization (NACI) and Health Canada respectively: (a) what scientific evidence, expert opinions, and other factors went into the decision to extend the dosing schedule up to four months between doses of the COVID-19 vaccines; and (b) what is the summary of the minutes of each meeting the NACI had in which dosing timelines were discussed?
In the House of Commons on April 26th, 2021. See this statement in context.